期刊文献+

人釉原蛋白编码区基因真核表达载体PsecTaq2A-AMG的构建 被引量:2

Construction of the Eukaryotic Expression Vector PsecTaq2A-AMG for Human Amelogenin
下载PDF
导出
摘要 目的 构建人釉原蛋白 (AMG)编码区基因真核表达载体PsecTaq2A_AMG。方法 采用PCR技术体外扩增AMG完整分泌肽编码区。将扩增产物与PsecTaq2A分别用BamHI和XholI行双酶切 ,将获取的AMG目的基因片段连接到双酶切后的PsecTaq2A ,构建重组质粒PsecTaq2A_AMG ,并对重组质粒进行鉴定。结果 ①PCR扩增产物经 1 5 %琼脂糖凝胶电泳 ,可见大小约 5 19bp的特异性条带 ,与预期结果一致。②重组克隆PsecTaq2A_AMG酶谱分析与预期结果一致 ,序列测定结果与GenBank中的人釉原蛋白序列完全一致。结论 用此方法可成功构建AMG编码区基因真核表达载体PsecTaq2A_AMG。 Objective\ The purpose of this study was to construct a eukaryotic expression vector for human amelogenin (AMG).Methods\ PCR was performed to amplify the AMG encoding region. Amplified fragments for human AMG were recovered and inserted into eukaryotic expression vectors PsecTaq2A. The recombinant plasmid PsecTaq2A_AMG was constructed and their positive clones were identified.Results\ ①Amplified products were checked by electrophoresis and the results were satisfactory. ②The recombinant plasmid PsecTaq2A_AMG was analyzed by restriction endonuclease mapping and DNA sequencing. The results of sequencing were consistent with those from GenBank.Conclusion\ The recombinant plasmid PsecTaq2A_AMG was successfully constructed with properly inserted DNA sequence encoding mature amelogenin.\;
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2003年第2期133-135,共3页 West China Journal of Stomatology
关键词 人釉原蛋白 重组质粒 编码区基因真核表达载体 基因治疗 human amelogenin \ recombinant plasmid \ PsecTaq2A_AMG\
  • 相关文献

参考文献10

  • 1Gestrelius S,Andersson C,Jonhasson AC,et al.Formulation of enamel matrix derivative foe surface coating Kinetics and cell colonization[].Journal of Clinical Periodontology.1997
  • 2Krebsbach PH,Keni G,Franceschi RT,et al.rasduced human fibroblasts form bone in vivo[].Human Gene Therapy.2000
  • 3Miller SC,Marks SCJr.Alveolar bone augmentation following the local administration of prostaglandin E1 by controlled_release pellets[].Bone.1993
  • 4Hammarstrom L.Enamel matrix, cementum development and regeneration[].Journal of Clinical Periodontology.1997
  • 5Lee MB.Bone morphogenetic proteins: Background and implications for oral reconstruction: A review[].Journal of Clinical Periodontology.1997
  • 6Evan JI,Lewis GK,Ramsay G,et al.Isolation of monoclonal antibodies specific for c_myc proto_oncogene product[].Molecular and Cellular Biology.1985
  • 7Graves DT,Kang YM,Kose KN.Growth factors in periodontal regeneration[].Compendium of Continuing Education in Dentistry.1994
  • 8Coloma MJ,Hastings A,Wims LA,et al.Novel vector for expression of antibody molecules using variable region generated by polymerase chain reaction[].Journal of Immunological Methods.1992
  • 9David LC,John MW.Biological mediators for periodontal regeneration[].Periodontology.2000
  • 10MacColl GS,Novo FJ,Marshall NJ,et al.Optimization of growth hormone production by muscle cells using plasmid DNA[].The Journal of Endocrinology.2000

同被引文献22

  • 1Andrades JA, Han B, Becerra J, et al. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells. Exp Cell Res, 1999,250(2):485-498
  • 2Ripamonti U, Crooks J, Matsaba T, et al. Induction of endochon-dral bone formation by recombinant human transforming growth factor-beta2 in the baboon (Papio ursinus). Growth Factors, 2000,17(4):269-285
  • 3Wozney JM. Bone morphogenetic proteins in periodontal re-construction. J Periodontol, 1995,66(6):506-510
  • 4Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA, 1990,87(6):2220-2224
  • 5Coloma MJ, Hastings A, Wims LA, et al. Novel Vector for expression of Antibody Molecules using variable Region Generated by Polymerase Chain Reaction. J Imm Methods, 1992,152(1):89-104
  • 6Hammarstrom L. Enamel Matrix, Cementum development and regener-ation. J Clin Periodontol, 1997,24(9Pt2):658-668
  • 7Hammarstrom L, Heiji L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol, 1997,24(9Pt2):669-677
  • 8Zetterstrom O, Andersson C, Eriksson L, et al. Clinical safety of Enamel Matrix Derivative (Emdogain) in the treatment of periodontal defects. J Clin Periodontol, 1997,24(9Pt2):697-704
  • 9Heijl L, Heden G, Svardstrom G, et al. Enamel matrix derivative (Emdogain) in the treatment of periodontal defects. J Clin Periodontol, 1997,24(9Pt2):705-714
  • 10Brookes SJ, Robinson C, Kirkham J, et al. Biochemistry and Molecular Biology of Amelogenin Proteins of Developing Dental Enamel. Archs Oral Biol, 1994,40(1):1-14

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部